Science News
from research organizations

Hot On The TRAIL Of Controlling Inflammation In Bacterial Meningitis

Date:
June 18, 2007
Source:
Journal of Clinical Investigation
Summary:
Researchers report that the molecule known as TRAIL can limit excessive immune responses in bacterial meningitis, and as such may be of use to control inflammation of the spinal cord and brain, which causes brain cell death in this life-threatening disease.
Share:
       
FULL STORY

Researchers at Charité -- Universitätsmedizin Berlin report that the molecule known as TRAIL can limit excessive immune responses in bacterial meningitis and as such may be of use to control inflammation of the spinal cord and brain, which causes brain cell death in this life-threatening disease.

Pneumococcal meningitis involves inflammation of the protective membranes covering the brain and spinal cord and is caused by infection with the bacterium Streptococcus pneumoniae. The observed swelling of the brain is largely the result of the excessive immune response to infection.

The tumor necrosis factor - related apoptosis-inducing ligand (TRAIL) has been previously reported to play a role in the regulation of the host immune response. In the current study, Joerg Weber and colleagues administered components of Streptococcus pneumoniae bacteria to the cerebrospinal fluid bathing the brain and spinal cord of mice lacking TRAIL. They found that these animals suffered from increased inflammation and brain cell death, however these effects were reversed by the administration of recombinant TRAIL (rTRAIL).

Importantly, the application of rTRAIL to mice with intact TRAIL and meningitis also decreased inflammation and neuronal cell death. Finally, the authors observed that human patients with bacterial meningitis showed increased synthesis in the cerebrospinal fluid of TRAIL. The results of the study provide evidence that TRAIL acts to limit inflammation of the brain and spinal cord during bacterial meningitis, suggesting that it may be of use as an anti-inflammatory agent in invasive bacterial infections.

Reference: "TRAIL limits excessive host immune responses in bacterial meningitis" June 14 oniine, July print issue of the Journal of Clinical Investigation


Story Source:

The above post is reprinted from materials provided by Journal of Clinical Investigation. Note: Materials may be edited for content and length.


Cite This Page:

Journal of Clinical Investigation. "Hot On The TRAIL Of Controlling Inflammation In Bacterial Meningitis." ScienceDaily. ScienceDaily, 18 June 2007. <www.sciencedaily.com/releases/2007/06/070617164102.htm>.
Journal of Clinical Investigation. (2007, June 18). Hot On The TRAIL Of Controlling Inflammation In Bacterial Meningitis. ScienceDaily. Retrieved August 1, 2015 from www.sciencedaily.com/releases/2007/06/070617164102.htm
Journal of Clinical Investigation. "Hot On The TRAIL Of Controlling Inflammation In Bacterial Meningitis." ScienceDaily. www.sciencedaily.com/releases/2007/06/070617164102.htm (accessed August 1, 2015).

Share This Page: